Cyclic regulation of transcription factor C/EBP beta in human endometrium by Plante, Beth J et al.
BioMed Central
Reproductive Biology and 
Endocrinology
ssOpen AcceResearch
Cyclic regulation of transcription factor C/EBP beta in human 
endometrium
Beth J Plante*†1, Athilakshmi Kannan†2, Milan K Bagchi2, Lingwen Yuan1 
and Steven L Young1
Address: 1Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of North Carolina School 
of Medicine, CB 7570, Old Clinic Building, Chapel Hill, NC 27599, USA and 2Department of Molecular & Integrative Physiology, University of 
Illinois at Urbana-Champaign, Urbana, IL, USA
Email: Beth J Plante* - bethplante@gmail.com; Athilakshmi Kannan - kalki32@uiuc.edu; Milan K Bagchi - mbagchi@life.uiuc.edu; 
Lingwen Yuan - lingwen_yuan@med.unc.edu; Steven L Young - steven_young@med.unc.edu
* Corresponding author    †Equal contributors
Abstract
Background: The transcription factor CCAAT/enhancer-binding protein (C/EBP) beta is a critical
mediator of murine endometrial function during embryo implantation. Our objective is to
characterize changes in C/EBP beta mRNA abundance and protein localization over the normal
human menstrual cycle.
Methods: Fifty normally cycling volunteers without reproductive disorders were randomized to
undergo endometrial sampling on a specific cycle day, with secretory phase samples timed using
urinary LH surge. Samples were assessed for relative C/EBP beta mRNA expression using
quantitative real-time RT-PCR and for C/EBP beta protein localization using
immunohistochemistry. The semiquantitative histologic scoring (HSCORE) system was used to
compare staining intensity in each tissue compartment between each cycle phase.
Results: C/EBP beta mRNA expression by whole endometrium peaks in the late secretory phase
and is significantly higher than that in the proliferative and mid-secretory phases. A marked increase
in nuclear C/EBP beta protein immunostaining is seen in stromal cells beginning about cycle day 20,
coincident with the start of endometrial receptivity. This increased staining continues for the
remainder of the cycle.
Conclusion: In the normal human menstrual cycle, C/EBP beta mRNA and protein expression also
change, with increased nuclear immunostaining in the mid-secretory phase, suggesting a possible
role for C/EBP beta in human endometrial receptivity.
Background
The transcription factor CCAAT/enhancer-binding pro-
tein (C/EBPβ) is a basic leucine zipper (bZIP) family tran-
scription factor [1]. bZIP proteins are involved in the
regulation of proliferation, differentiation, metabolic
homeostasis, acute phase inflammation, and apoptosis
[1-3]. C/EBPβ, in particular, is known to regulate prolifer-
ation and differentiation in many target tissues, including
liver, adipose tissue, immune cells, skin cells, the ovary,
and mammary glands. Depending on the tissue type, C/
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lar proliferation [1,4-7].
C/EBPβ is a critical mediator of murine endometrial func-
tion during embryo implantation. Murine C/EBPβ expres-
sion rises rapidly in endometrial epithelium at the time of
blastocyst attachment and increases in the endometrial
stromal cells around the conceptus during decidualiza-
tion [8]. Female mice lacking the C/EBPβ gene are infertile
due to implantation failure and the uteri of these mice fail
to decidualize in response to a mechanical stimulus.
Administration of estrogen or progesterone to ovariect-
omized mice induces C/EBPβ expression in both uterine
epithelium and stroma, suggesting that both hormones
are involved in the regulation of this gene [8].
While the mouse model suggests that C/EBPβ is regulated
by sex steroids and plays an essential role in regulating
endometrial function, relatively little is known about C/
EBPβ expression and function in human endometrium.
Previous studies have demonstrated the presence of C/
EBPβ mRNA in human endometrium and upregulation of
C/EBPβ during in vitro decidualization of endometrial
stromal cells [9-12]. Previous studies on in vivo regulation
of C/EBPβ expression by human endometrium have been
limited to small sample sizes and have not allowed spe-
cific assessment of the embryo-receptive (mid-secretory)
phase of the cycle [11]. Furthermore, no previous work
has specifically examined changes in C/EBPβ mRNA
abundance.
The purpose of our work is to further define the role of C/
EBPβ in human endometrium by characterizing changes
in C/EBPβ mRNA abundance, as well as the cellular and
subcellular localization of C/EBPβ protein over each func-
tional phase of the normal human menstrual cycle.
Methods
Human subjects
50 normal volunteer subjects (ages 18–35, mean age 27
years) with regular cycles (ranging from 25 to 35 days)
were randomized to undergo endometrial sampling on a
specific cycle day under a protocol approved by the Insti-
tutional Review Board at the University of North Carolina
at Chapel Hill. These volunteers had no anatomic or func-
tional abnormalities of the reproductive tract and were
not taking any medications known to affect reproductive
hormone production or action. Proliferative phase sam-
ples were timed based on the patient's cycle day, and
luteal phase samples were timed using the subject's uri-
nary luteinizing hormone (LH) surge.
Each biopsy was separated into aliquots, with a fraction
reserved for RNA analysis and a fraction reserved for fixa-
tion in formalin. The portions designated for RNA analy-
sis were flash frozen in liquid nitrogen. The formalin-fixed
portions were embedded in paraffin, and sectioned for
both immunohistochemistry and staining with hematox-
ylin and eosin (H&E). Endometrial histology of the H&E
sections were evaluated by a single observer (SLY), who
was blinded to cycle day and confirmed LH dating in all
cases. Samples were categorized as either proliferative (n =
23), early secretory (n = 6), mid-secretory (n = 15), or late
secretory (n = 6). All 50 samples were used for quantita-
tive real-time reverse transcriptase-polymerase chain reac-
tion (RT-PCR). Eleven of these samples were used for
immunohistochemistry, in addition to nine previously
collected samples. The 20 samples used for immunohisto-
chemistry were evenly distributed throughout the men-
strual cycle. One slide was of poor quality and was not
suitable for H-scoring. Two additional slides did not
exhibit any luminal tissue and were, therefore, excluded
from scoring for that particular compartment.
RNA isolation and quantification
Quantitative real-time RT-PCR was performed on total
RNA, in triplicate, using probe-primer sets specific for C/
EBPβ and the constitutively-expressed gene, cyclophilin
(PPIA) (Gene Expression Assays, Applied Biosystems –
assay ID HS00270923_s1 (C/EBPβ) and
HS99999904_m1 (PPIA)). These probe-primer sets cross
introns, and therefore, are expected to provide signal only
from mRNA and not from genomic DNA. Cyclophilin was
chosen because previous work suggested that cyclophilin
exhibits little variation across the menstrual cycle (SLY
unpublished data). In the current experiment, Ct values
were consistent between samples, further confirming the
constitutive expression of this gene.
Endometrial total RNA was isolated from frozen tissue
samples using the RNAqueous-4 PCR Kit (Ambion)
according to the manufacturer's suggested conditions.
RNA quantification was performed using RiboGreen (Inv-
itrogen) with a ribosomal RNA standard curve. First
strand complementary DNA (cDNA) was synthesized
from 500 ng of total RNA (Roche 1st Strand cDNA Synthe-
sis Kit for RT-PCR). An equivalent volume of water was
substituted for the RNA for each reaction as a "no tem-
plate" negative control. The total reaction volume was 20
μl, and reverse transcription conditions were 25°C for 10
minutes, 42°C for 60 minutes, 99°C for 5 minutes.
Each sample of cDNA was diluted 1:5, and plated in trip-
licate with TaqMan Master Mix (Applied Biosystems) and
sterile water. Primers and probes for C/EBPβ and cyclo-
philin (PPIA) were obtained in a predesigned mix for each
gene. The total reaction volume for all real-time PCR
experiments was 20 μl. Reactions were performed in 96-
well plates on a Stratagene MX3000 device for 40 2-step
cycles (95°C for 25 seconds and then 60°C for 1 minute).Page 2 of 8
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and 82.3% (PPIA). The average cycle number at which the
TaqMan fluorescence became detectable above the thresh-
old (Ct) was 25.9 (C/EBPβ) and 25.4 (PPIA). Ct values
were converted to relative expression using the delta-delta
Ct method, allowing normalization to both the house-
keeping gene, PPIA, and a single sample in the prolifera-
tive phase. The RT-PCR data were grouped by cycle phase
and analyzed by one way analysis of variance using
Tukey's Multiple Comparison Test for post hoc analysis.
Immunohistochemistry
Paraffin embedded endometrial sections were deparaffin-
ized in xylene, rehydrated in decreasing concentrations of
ethanol, and rinsed in phosphate buffered saline for five
minutes. Antigen retrieval was performed using 0.1 M cit-
rate buffer at pH 6.0. Endogenous peroxidase activity was
blocked by incubating the slides with 0.3% H2O2 in meth-
anol for 30 minutes. Slides were washed in water followed
by incubation with 10% goat serum in PBS for an hour at
room temperature to block non-specific binding. The sec-
tions were then incubated with a rabbit polyclonal anti-
body against C/EBPβ (C-19, Santa Cruz Biotechnology,
Santa Cruz, CA) diluted 1:200 in blocking solution in a
humid chamber overnight at 4°C. The sections were then
incubated with goat anti-rabbit biotinylated IgG (Histo-
stain Kit, Zymed Laboratories Inc., San Francisco, CA) for
thirty minutes. Finally, horseradish peroxidase (HRP)-
conjugated streptavidin was added and incubation was
performed for thirty minutes at room temperature. The
sections were stained in aminoethylcarbazole (AEC) solu-
tion (Zymed Laboratories Inc., San Francisco, CA) for one
to three minutes until optimal signals were obtained. In
addition, adjacent sections with no primary antibody
were used as controls.
Staining intensity and location was measured by two
independent observers using the semiquantitative histo-
logic scoring (HSCORE) system. The following equation
was used to calculate HSCORES: HSCORE = ΣPi (I + 1). I
represents the staining intensity (values of 1, 2, or 3 sig-
nify weak, moderate, or strong staining, respectively), and
Pi is the percentage of stained cells for each intensity cate-
gory (ranging from 0–100%). Previous work has demon-
strated the low intraobserver and interobserver variability
of the HSCORE system applied to immunostaining of
endometrium [13]. Disagreements in HSCORE were
resolved by consensus conference between the observers.
The HSCORES were grouped by cycle phase and analyzed
by one way analysis of variance using Tukey's Multiple
Comparison Test for post hoc analysis.
Results
Timed endometrial biopsies from healthy volunteers were
obtained in the proliferative (n = 23), early secretory (n =
6), mid-secretory (n = 15), or late secretory (n = 6) phase
of the menstrual cycle and RNA was extracted. Relative
expression of C/EBPβ mRNA by whole endometrium was
found to peak in the late secretory phase and was signifi-
cantly higher than that in the proliferative (P < 0.01) and
mid-secretory phases (P < 0.001) (Figure. 1). The increase
in the late secretory phase mRNA was predominantly due
to marked increases at 13 and 14 days after the LH surge.
In order to correlate C/EBPβ mRNA and protein expres-
sion, as well as characterize the cellular and subcellular
localization of C/EBPβ protein over the normal human
menstrual cycle, immunohistochemical analysis was per-
formed (Figure. 2). HSCOREs were analyzed in order to
more accurately quantify the immunohistochemical find-
ings. Composite HSCORES of overall endometrial C/
EBPβ immunostaining (nuclear plus cytoplasmic stain-
ing) revealed no significant change across the menstrual
cycle, whether taken as a whole or specifically in stroma,
glands, or luminal compartments (not shown).
C/EBPβ, however, acts specifically in the nucleus, and spe-
cific assessment of nuclear staining demonstrated signifi-
Endometrial C/EBPβ mRNA expressionFigure 1
Endometrial C/EBPβ mRNA expression. Relative 
expression of C/EBPβ mRNA by whole endometrium across 
the menstrual cycle (P = proliferative, ES = early secretory, 
MS = mid-secretory, LS = late secretory). *C/EBPβ expres-
sion in the late secretory phase was significantly higher than 
that in the proliferative (P < 0.01) and mid secretory phases 
(P < 0.001).Page 3 of 8
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Immunohistochemical C/EBPβ localization across the menstrual cycleFigure 2
Immunohistochemical C/EBPβ localization across the menstrual cycle. Proliferative phase (A, B). Early secretory 
phase (C, D). Mid-secretory phase (E, F). Late secretory phase (G, H). C/EBPβ staining is shown in A, C, E, and G, while con-
trols for non-specific staining (B, D, F, and H) utilized identical conditions except the primary antibody was omitted.
C/EBPβ CONTROL
Proliferative
Early Secretory
Mid-Secretory
Late Secretory
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Stromal nuclei demonstrated low staining in the prolifer-
ative and early secretory phases with significant increases
in the mid- and late secretory phases (p < 0.05) (Figure. 2
& Figure 3A).
An increase in glandular cytoplasmic staining was seen
during the secretory phase, but nuclear staining showed a
significant decrease when compared with the proliferative
phase (p < 0.01)(Figure. 3B). While the change in nuclear
staining was statistically significant, its physiologic signif-
icance is questionable since glandular nuclear staining
was very weak across the entire cycle. Modest luminal
nuclear staining for C/EBPβ was seen throughout the
menstrual cycle, with a non-significant trend towards
increasing in the mid-secretory phase (Figure. 2 and Fig-
ure 3C).
Discussion
Murine studies demonstrate that C/EBPβ plays an essen-
tial role in mediating the biological activity of estrogen
and progesterone in the mouse uterus at the time of
embryo implantation [1,8]. C/EBPβ mRNA is also present
in human endometrium and is upregulated in vitro dur-
ing stromal cell decidualization [9-12]. The purpose of
our work has been to further define the role of C/EBPβ in
human endometrium by characterizing changes in C/
EBPβ mRNA abundance, as well as the cellular and subcel-
lular localization of C/EBPβ protein over the normal
human menstrual cycle.
Our mRNA results demonstrate peak C/EBPβ mRNA
expression in the late secretory phase in whole samples of
human endometrium, primarily at LH+13 and LH+14,
with no increase seen in the mid-secretory phase. The
finding of very late secretory increase suggests a potential
role for increased C/EBPβ in preparation for menstrua-
tion. The lack of a mid-secretory mRNA increase was sur-
prising, since human stromal decidualization begins
during this phase. Additionally, C/EBPβ is induced in
human endometrial stromal cells by in vitro decidualiza-
tion, and previous microarray studies of human
endometrium showed a small (< 2-fold) increase in the
mid-secretory versus early secretory phase and a further
small (< 2-fold) increase in the late secretory versus mid-
secretory phase [9]. Furthermore, C/EBPβ plays a critical
role in murine endometrial decidualization. The apparent
discrepancy in our mid-secretory findings versus previous
microarray data may be explained, in part, by the relative
lack of precision of microarray studies or a change too
small to be easily seen by RT-PCR. Alternatively, these dif-
ferences may simply be due to individual variations
within human cycle phases.
In order to shed further light on the mRNA results and
clarify the cellular and subcellular localization of C/EBPβ
protein, immunohistochemical analysis was performed. A
slight increase in C/EBPβ cytoplasmic staining is seen in
the glands during the secretory phase. This glandular
staining, however, is primarily cytoplasmic and may rep-
resent an inactive form of C/EBPβ, because the active,
DNA binding, phosphorylated form of C/EBPβ localizes
to the nucleus. Depending on the physiological state of
the endometrial cells, C/EBPβ may be present in the cyto-
plasm before being activated by a phosphorylation event
and subsequently translocated to the nucleus [14-16].
Nuclear immunostaining increases markedly in the sub-
epithelial stromal cells in the mid-secretory phase. It is of
particular interest that the increase in stromal C/EBPβ
nuclear staining coincides with the opening of the win-
dow of receptivity to embryo implantation. Overall, the
human stromal C/EBPβ immunohistochemical findings
are consistent with those in the murine model as both sys-
tems show a rise in C/EBPβ during the receptive phase [8].
Additionally, beginning in the mid-secretory phase, stro-
mal cells undergo predecidualization. C/EBPβ 's increased
stromal nuclear expression may indicate a role for this
transcription factor during this differentiation process.
This rise in nuclear stromal C/EBPβ staining seen in the
human during the mid- and late-secretory phases is con-
sistent with the murine rise during decidualization.
Human endometrial stroma undergoes partial deciduali-
zation (predecidulaization) in the mid-secretory phase,
whereas murine stroma normally decidualizes only dur-
ing implantation. In both cases, increased nuclear stromal
C/EBPβ staining is seen in conjunction with the decidual-
ization process.
When taken together, the mRNA and protein analyses
illustrate provocative changes in C/EBPβ expression
across the human menstrual cycle. The RT-PCR findings
help to accurately quantify relative changes in C/EBPβ
mRNA expression in whole endometrium throughout the
menstrual cycle. These results represent a composite pic-
ture of the changes in epithelial and stromal expression of
C/EBPβ. Differences between composite endometrial
mRNA and immunohistochemical findings may be due to
differences in cytoplasmic versus nuclear localization. For
instance, a change in overall expression of C/EBPβ may
mask a modest but significant enhancement in nuclear
expression in a given compartment. Furthermore, C/EBPβ
expression has been documented in immune cells where
it is important for macrophage cytokine expression and B-
lymphocyte function [17]. Additionally, there is a known
influx of immune cells, including macrophages, into
endometrial stroma prior to menstruation [18]. Because
of this relationship, we speculate that the late secretoryPage 5 of 8
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HSCORES of nuclear C/EBPβ endometrial immunostainingFigure 3
HSCORES of nuclear C/EBPβ endometrial immunostaining. HSCORES of nuclear endometrial immunostaining for C/
EBPβ in stroma (A), glands (B), and lumen (C) across the menstrual cycle. *HSCORES reveal a significant increase in nuclear 
stromal C/EBPβ expression in the mid- and late secretory phases.(p < 0.05). Nuclear glandular staining was significantly higher 
in the proliferative phase compared to the secretory phase (p < 0.01).
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Reproductive Biology and Endocrinology 2009, 7:15 http://www.rbej.com/content/7/1/15rise in endometrial C/EBPβ mRNA may be due to this
influx of immune cells.
To our knowledge, this paper is the first description of C/
EBPβ expression that allows analysis of changes in expres-
sion over each functional stage of endometrial differenti-
ation. Previous work demonstrated diffuse cellular
localization of C/EBPβ protein in human endometrium
[11], but our current findings demonstrate the expected
nuclear localization of this transcription factor in both the
luminal and stromal compartments during the receptive
phase of the menstrual cycle. These discrepancies may be
due to differences in the immunohistochemistry proto-
cols that were employed. This previous work was also
somewhat limited by relatively few samples of human
endometrium (eighteen total). In addition, the three func-
tional phases of secretory endometrium were not ana-
lyzed separately, presumably because of the small pool of
available samples. Instead, specimens from the secretory
phase were simply categorized as either early or late secre-
tory. Such a classification system omits a separate analysis
of the mid-secretory samples, which would be the samples
of most interest as they should reflect endometrial
changes during the window of endometrial receptivity to
embryo implantation.
Conclusion
In summary, C/EBPβ mRNA and protein expression
noticeably change throughout the normal human men-
strual cycle and particularly during the embryo-receptive
phase, suggesting a possible role for C/EBPβ in human
endometrial function and embryo implantation. Human
stromal C/EBPβ protein changes are largely consistent
with those in the murine model. Further studies are
needed to elucidate the precise mechanisms by which C/
EBPβ influences these biological processes in normal
human endometrium. In addition, potential differences
in C/EBPβ expression in the endometrium of infertile
women remain unknown but warrant investigation.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
BJP assisted with the recruitment of human subjects and
endometrial sampling, participated in the RT-PCR, per-
formed manual HSCORES, and drafted the manuscript.
AK performed the immunohistochemistry and assisted
with experimental design. MKB conceived of the study in
conjunction with SLY, participated in its design and coor-
dination, and helped to draft the manuscript. LY carried
out the RNA isolation and quantification and provided
significant input into experimental method development.
SLY conceived of the study in conjunction with MKB, par-
ticipated in its design and coordination, assisted with the
manual HSCORES, helped with the statistical analysis,
and helped to draft the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
We acknowledge the outstanding technical assistance of Ms. Xi Yang in all 
real-time PCR experiments. We would also like to acknowledge the follow-
ing financial support: Eunice Kennedy Shriver NICHD/NIH through coop-
erative agreement U54HD035041-11 (SLY) and NICHD U54 HD 055787 
(MKB) as part of the Specialized Cooperative Centers Program in Repro-
duction and Infertility Research and UNC Nova Carta Foundation, Chapel 
Hill, NC to SLY.
References
1. Bagchi MK, Mantena SR, Kannan A, Bagchi IC: Control of uterine
cell proliferation and differentiation by C/EBPbeta: func-
tional implications for establishment of early pregnancy.  Cell
Cycle 2006, 5(9):922-925.
2. McKnight SL: McBindall – a better name for CCAAT/enhancer
binding proteins?  Cell 2001, 107(3):259-261.
3. Ramji DP, Foka P: CCAAT/enhancer-binding proteins: struc-
ture, function and regulation.  Biochem J 2002, 365(Pt
3):561-575.
4. Greenbaum LE, Li W, Cressman DE, Peng Y, Ciliberto G, Poli V, Taub
R: CCAAT enhancer-binding protein beta is required for
normal hepatocyte proliferation in mice after partial hepate-
ctomy.  J Clin Invest 1998, 102(5):996-1007.
5. Zhu S, Yoon K, Sterneck E, Johnson PF, Smart RC: CCAAT/
enhancer binding protein-beta is a mediator of keratinocyte
survival and skin tumorigenesis involving oncogenic Ras sig-
naling.  Proc Natl Acad Sci USA 2002, 99(1):207-212.
6. Robinson GW, Johnson PF, Hennighausen L, Sterneck E: The C/
EBPbeta transcription factor regulates epithelial cell prolif-
eration and differentiation in the mammary gland.  Genes Dev
1998, 12(12):1907-1916.
7. Seagroves TN, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darling-
ton GJ, Rosen JM: C/EBPbeta, but not C/EBPalpha, is essential
for ductal morphogenesis, lobuloalveolar proliferation, and
functional differentiation in the mouse mammary gland.
Genes Dev 1998, 12(12):1917-1928.
8. Mantena SR, Kannan A, Cheon YP, Li Q, Johnson PF, Bagchi IC, Bagchi
MK: C/EBPbeta is a critical mediator of steroid hormone-
regulated cell proliferation and differentiation in the uterine
epithelium and stroma.  Proc Natl Acad Sci USA 2006,
103(6):1870-1875.
9. Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, Le
Shay N, Nezhat CN, Kempson R, Lessey BA, Nayak NR, Giudice LC:
Molecular phenotyping of human endometrium distin-
guishes menstrual cycle phases and underlying biological
processes in normo-ovulatory women.  Endocrinology 2006,
147(3):1097-1121.
10. Pohnke Y, Kempf R, Gellersen B: CCAAT/enhancer-binding pro-
teins are mediators in the protein kinase A-dependent acti-
vation of the decidual prolactin promoter.  J Biol Chem 1999,
274(35):24808-24818.
11. Christian M, Zhang X, Schneider-Merck T, Unterman TG, Gellersen
B, White JO, Brosens JJ: Cyclic AMP-induced forkhead tran-
scription factor, FKHR, cooperates with CCAAT/enhancer-
binding protein beta in differentiating human endometrial
stromal cells.  J Biol Chem 2002, 277(23):20825-20832.
12. Pohnke Y, Schneider-Merck T, Fahnenstich J, Kempf R, Christian M,
Milde-Langosch K, Brosens JJ, Gellersen B: Wild-type p53 protein
is up-regulated upon cyclic adenosine monophosphate-
induced differentiation of human endometrial stromal cells.
J Clin Endocrinol Metab 2004, 89(10):5233-5244.
13. Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG,
Creasman WT, Flowers JL, McCarty KS Jr: Immunohistochemical
analyses of estrogen receptor in endometrial adenocarci-
noma using a monoclonal antibody.  Cancer Res 1986,
46(10):5419-5425.
14. Tang QQ, Gronborg M, Huang H, Kim JW, Otto TC, Pandey A, Lane
MD: Sequential phosphorylation of CCAAT enhancer-bind-Page 7 of 8
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2009, 7:15 http://www.rbej.com/content/7/1/15Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
ing protein beta by MAPK and glycogen synthase kinase
3beta is required for adipogenesis.  Proc Natl Acad Sci USA 2005,
102(28):9766-9771.
15. Buck M, Zhang L, Halasz NA, Hunter T, Chojkier M: Nuclear
export of phosphorylated C/EBPbeta mediates the inhibition
of albumin expression by TNF-alpha.  EMBO J 2001,
20(23):6712-6723.
16. Li X, Kim JW, Gronborg M, Urlaub H, Lane MD, Tang QQ: Role of
cdk2 in the sequential phosphorylation/activation of C/EBP-
beta during adipocyte differentiation.  Proc Natl Acad Sci USA
2007, 104(28):11597-11602.
17. Li H, Gade P, Xiao W, Kalvakolanu DV: The interferon signaling
network and transcription factor C/EBP-beta.  Cell Mol Immu-
nol 2007, 4(6):407-418.
18. Young S, Loy T: Normal Cycling Endometrium: Molecular,
Cellular, and Histologic Perspectives.  In Endometriosis in Clinical
Practice 1st edition. Edited by: Olive D. Informa HealthCare;
2004:1-12. Page 8 of 8
(page number not for citation purposes)
